Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets-Reference-Cited by-同舟云学术

Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets

Published:2017-08-04 Issue:12 Volume:30 Page:1698-1709
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Heitzer Ellen^ORCID,Sunitsch Sandra,Gilg Magdalena M,Lohberger Birgit,Rinner Beate,Kashofer Karl,Stündl Nicole,Ulz Peter^ORCID,Szkandera Joanna,Leithner Andreas,Liegl-Atzwanger Bernadette

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol201794.pdf

Reference44 articles.

1. Neuville A, Ranchere-Vince D, Dei Tos AP et al. Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study. Am J Surg Pathol 2013;37:1259–1268.

2. Antonescu CR . The role of genetic testing in soft tissue sarcoma. Histopathology 2006;48:13–21.

3. Fletcher CDM World Health Organization, International Agency for Research on Cancer WHO Classification of Tumours of Soft Tissue and Bone. IARC Press: Lyon, 2013.

4. Weiss SW, Enzinger FM . Myxoid variant of malignant fibrous histiocytoma. Cancer 1977;39:1672–1685.

5. Angervall L, Kindblom LG, Merck C . Myxofibrosarcoma. A study of 30 cases. Acta Pathol Microbiol Scand A 1977;85A:127–140.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment and characterization of two novel patient-derived cell lines from myxofibrosarcoma: NCC-MFS7-C1 and NCC-MFS8-C1;Human Cell;2024-08-31

2. p53 as a Potential Actionable Target in Myxofibrosarcoma: A Molecular and Pathologic Review of a Single-Institute Series;Laboratory Investigation;2024-08

3. The Role of Methylation Analysis in Distinguishing Cellular Myxoma from Low-Grade Myxofibrosarcoma;International Journal of Molecular Sciences;2024-05-08

4. Establishment and characterization of two novel patient-derived cell lines from myxofibrosarcoma: NCC-MFS7-C1 and NCC-MFS8-C1;2024-04-19

5. Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma;American Journal of Surgical Pathology;2024-02-19